LLY News and Press, Eli Lilly and Company From 02/05/24

2024-02-05 12:38:30 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked Eli Lilly sees highest intraday trade since November...

Eli Lilly and Company (NYSE: LLY) is one of today's top gainers. The company's shares have moved 1.09% on the day to $667.65. Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Hu...

2024-02-05 10:51:44 ET More on Eli Lilly Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Biotech And Pharma Diversification Pays Off Eli Lilly: The Cupboard Is Fully Stocked U.S. govt. opens bids in Medicare drug price negotia...

2024-02-05 10:48:55 ET More on S&P 500 Index: I Think The Bulls Win Either Way The U.S. Dollar And Rates Rise Further SP500: Major Deflationary Warning - Rents Are Collapsing Paul Tudor Jones: The economy is in an unsustainable path S&P, Nasda...

2024-02-05 06:35:53 ET More on Amgen Amgen: Debt-Funded Buybacks Constrains Future Gains Per Share Amgen: Accelerating The Business And Dividend Growth Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks Earnings week ahead: Alibaba, Pepsi...

2024-02-04 12:07:00 ET Summary Fed Chairman Powell kicks off the Fed speaker parade, with the odds of a March cut rising again despite the data. The SLOOS report is back in the spotlight amid regional bank weakness. Super Bowl prop bets could surge with the Taylor Swift and Tr...

2024-02-04 08:45:00 ET As Wall Street embarks on the first full week of February, a large number of companies are set to release their earnings reports, providing a crucial glimpse into their financial standing and future outlook. From industry leaders like The Walt Disney Company (...

2024-02-04 08:05:00 ET Summary Bristol-Myers Squibb has faced revenue stagnation and a decline in stock price, but recent Q4 results suggest a potential rebound in top-line growth. BMY's in-line and new product portfolio showed strong sales growth, driven by top drugs like Eliquis...

2024-02-04 04:05:00 ET Eli Lilly 's (NYSE: LLY) shares have soared over the past year, and for good reason. The drugmaker is a leader in one of the fastest-growing pharma segments today -- the weight-loss drug market. Eli Lilly sells Mounjaro, a type 2 diabetes drug that doctors als...

2024-02-02 15:00:00 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...